61 related articles for article (PubMed ID: 1000028)
1. Plasma prolactin response to L-dopa TRH and metaclopramide in thyrotoxicosis.
Delitala G; Masala A; Alagna S; Devilla L
Biomedicine; 1976 Jul; 25(5):173-6. PubMed ID: 1000028
[TBL] [Abstract][Full Text] [Related]
2. Dose-dependency and reproducibility of the prolactin response to metoclopramide.
Kitaoka M; Takebe K; Kobayashi M; Nakazono M; Kudo M
Horm Metab Res; 1980 Apr; 12(4):155-8. PubMed ID: 6771199
[TBL] [Abstract][Full Text] [Related]
3. Decreased prolactin responsiveness to thyrotrophin-releasing hormone and metoclopramide in hyperthyroidism.
Röjdmark S; Carlsson A
Acta Endocrinol (Copenh); 1985 Oct; 110(2):221-6. PubMed ID: 2998132
[TBL] [Abstract][Full Text] [Related]
4. Metaclopramide and prolactin secretion in man: effects of pretreatment with L-dopa and 2-bromo-alpha-ergocryptine (CB-154).
Delitala G; Masala A; Alagna S; Devilla L
IRCS J Med Sci; 1975 Jun; 3(6):274. PubMed ID: 1165172
[No Abstract] [Full Text] [Related]
5. Effects of antidepressant treatment on thyrotropin-releasing hormone stimulation, growth hormone response to L-DOPA, and dexamethasone suppression tests in major depressive patients.
Esel E; Kartalci S; Tutus A; Turan T; Sofuoglu S
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):303-9. PubMed ID: 14751427
[TBL] [Abstract][Full Text] [Related]
6. Effect of bicalutamide therapy on prolactin response to L-dopa in metastatic prostate cancer patients.
Lissoni P; Malugani F; Casu M; Bukovec R; Egardi R; Bordin V; Fumagalli E; Mengo S; Gardani G
Neuro Endocrinol Lett; 2002 Feb; 23(1):61-3. PubMed ID: 11880864
[TBL] [Abstract][Full Text] [Related]
7. Thyroid hormone inhibition of the prolactin response to thyrotropin-releasing hormone.
Snyder PJ; Jacobs LS; Utiger RD; Daughaday WH
J Clin Invest; 1973 Sep; 52(9):2324-9. PubMed ID: 4199418
[TBL] [Abstract][Full Text] [Related]
8. Paradoxical stimulation of prolactin secretion by L-dopa in metastatic prostate cancer and its possible role in prostate-cancer-related hyperprolactinemia.
Lissoni P; Mandalà M; Rovelli F; Casu M; Rocco F; Tancini G; Scardino E
Eur Urol; 2000 May; 37(5):569-72. PubMed ID: 10765095
[TBL] [Abstract][Full Text] [Related]
9. Abnormal growth hormone responsiveness to stimuli in women with active celiac sprue.
Peracchi M; Molteni N; Cantalamessa L; Bardella MT; Peracchi G; Orsatti A; Faggioli P; Bianchi PA
Am J Gastroenterol; 1992 May; 87(5):580-3. PubMed ID: 1595643
[TBL] [Abstract][Full Text] [Related]
10. [The effects of l-dopa administration on the prolactin levels in short-stature subjects].
Saggese G; Cesaretti G; Carlotti C; Cioni C; Bracaloni C
Minerva Pediatr; 1992 Mar; 44(3):73-8. PubMed ID: 1518496
[TBL] [Abstract][Full Text] [Related]
11. Pyridoxine and depression: neuroendocrine aspects.
Casacchia M; Boni B; Meco G
Acta Vitaminol Enzymol; 1982; 4(1-2):55-8. PubMed ID: 6812398
[TBL] [Abstract][Full Text] [Related]
12. [Reevaluation of the I-dopa test in acromegaly: anatomo-clinical and prognostic correlations].
De Marinis L; Mancini A; Zuppi P; Fiumara C; Iacona T; Conte G; Fabrizi ML; Valle D; Anile C; Maira G
Minerva Chir; 1993 Nov; 48(21-22):1337-40. PubMed ID: 8152567
[TBL] [Abstract][Full Text] [Related]
13. L-DOPA attenuates prolactin secretion in response to isolation stress in Holstein steers.
Kasuya E; Yayou K; Sutoh M
Anim Sci J; 2013 Jul; 84(7):562-8. PubMed ID: 23607456
[TBL] [Abstract][Full Text] [Related]
14. [Possible mechanisms of the interaction between gonadotropins and prolactin in an experimental hyperprolactinemia model].
Tresguerres JA; Esquifino AI
Acta Physiol Lat Am; 1983; 33(3):257-74. PubMed ID: 6424409
[TBL] [Abstract][Full Text] [Related]
15. [Hyperthyroidism and subjects hyperresponding to thyrotropin. Importance of simultaneous thyrotropin and prolactin determination following administration of thyroid-releasing hormone].
Schlienger JL; De Laharpe F; Reville P; Stephan F
Sem Hop; 1980 May 8-15; 56(17-18):827-31. PubMed ID: 6248964
[TBL] [Abstract][Full Text] [Related]
16. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
Ishibashi M; Yamaji T
J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
[TBL] [Abstract][Full Text] [Related]
17. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
Foley TP; Jacobs LS; Hoffman W; Daughaday WH; Blizzard RM
J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
[TBL] [Abstract][Full Text] [Related]
18. Hypothalamic dysfunction in Parkinson's disease patients.
Otake K; Oiso Y; Mitsuma T; Hirooka Y; Adachi K
Acta Med Hung; 1994; 50(1-2):3-13. PubMed ID: 7638039
[TBL] [Abstract][Full Text] [Related]
19. Effect of metoclopramide and L-dopa on a single dose metyrapone test in normal men.
Matsuki M; Nishida S; Nagase Y; Horino M; Endoh M; Kakita K; Tenku A; Oyama H
Horm Metab Res; 1983 Oct; 15(10):519-21. PubMed ID: 6315558
[No Abstract] [Full Text] [Related]
20. The effect of cysteamine, cystamine, and the structurally related compounds taurine, N-acetyl-cysteine, and D-penicillamine on plasma prolactin levels in normal and estrogen-primed hyperprolactinemic rats.
Scott JS; Lakin CA; Oliver JR
Endocrinology; 1987 Aug; 121(2):812-8. PubMed ID: 3109888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
